Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orion Oyj B | Helsinki | Healthcare | Pharmaceuticals | €6.57B | 28.3x | -1.2 | €46.79 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.9% Downside | Upgrade to Pro+ | |
Orion Oyj A | Helsinki | Healthcare | Pharmaceuticals | €6.54B | 28.5x | -1.2 | €46.55 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terveystalo | Helsinki | Healthcare | Healthcare Providers & Services | €1.25B | -54.6x | 0.12 | €9.83 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.6% Upside | Upgrade to Pro+ | |
Revenio Group | Helsinki | Healthcare | Healthcare Equipment & Supplies | €907.99M | 46.8x | 34.64 | €34 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.6% Downside | Upgrade to Pro+ | |
Faron Pharmaceuticals Oy | Helsinki | Healthcare | Biotechnology & Medical Research | €255.47M | -5.3x | -1.5 | €2.51 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.1% Upside | Upgrade to Pro+ | |
Pihlajalinna Oy | Helsinki | Healthcare | Healthcare Providers & Services | €221.19M | 21.5x | 6.4 | €9.84 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.6% Upside | Upgrade to Pro+ | |
Nightingale Health Oyj | Helsinki | Healthcare | Healthcare Equipment & Supplies | €212.40M | -3.5x | -6.38 | €3.39 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -54.5% Downside | Upgrade to Pro+ | |
Oriola-KD Oyj A | Helsinki | Healthcare | Pharmaceuticals | €178.87M | -7.1x | 0.54 | €0.99 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oriola-KD Oyj B | Helsinki | Healthcare | Pharmaceuticals | €165.99M | -7.7x | 0.54 | €0.91 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.5% Upside | Upgrade to Pro+ | |
Nanoform Finland Plc | Helsinki | Healthcare | Biotechnology & Medical Research | €150.02M | -6.7x | -11.23 | €1.71 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Optomed | Helsinki | Healthcare | Healthcare Equipment & Supplies | €98.96M | -17.2x | -1.14 | €4.93 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.8% Upside | Upgrade to Pro+ | |
Bioretec Oy | Helsinki | Healthcare | Healthcare Equipment & Supplies | €55.11M | €2.68 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Modulight Oyj | Helsinki | Healthcare | Healthcare Equipment & Supplies | €48.53M | -4.2x | 0.09 | €1.15 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.2% Upside | Upgrade to Pro+ | |
Herantis Pharma Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €29.84M | -44.8x | -0.57 | €1.48 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nexstim | Helsinki | Healthcare | Healthcare Equipment & Supplies | €25.44M | -24.7x | -0.41 | €3.64 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.6% Downside | Upgrade to Pro+ | |
BBS-Bioactive Bone Substitutes Oyj | Helsinki | Healthcare | Healthcare Equipment & Supplies | €6.05M | -1.4x | €0.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22.2% Downside | Upgrade to Pro+ | ||
BBS | Helsinki | Healthcare | Healthcare Equipment & Supplies | €5.95M | -1.4x | €0.30 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ |